Tsubota Laboratory Incorporated

As of March 31, 2026, Tsubota Laboratory Incorporated carries a market capitalization of 7.58B, placing it among publicly traded companies globally. Its enterprise value stands at 6.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Tsubota Laboratory Incorporated's next confirmed earnings release is scheduled for November 11, 2026.

As of March 31, 2026, Tsubota Laboratory Incorporated has 25.79M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Tsubota Laboratory Incorporated maintains a current ratio of 3.14, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Tsubota Laboratory Incorporated's stock has declined approximately 25.15% over the past 52 weeks. The 50-day moving average sits at 269.86, while the 200-day moving average is 281.40.

As of March 31, 2026, Tsubota Laboratory Incorporated holds 969.85M in cash and equivalents against 69.21M in total debt, resulting in a net debt position of -900.63M. Total book value stands at 863.86M, with working capital of 873.10M providing operational flexibility.